Smith-modified Sgarbossa criteria (also searched with possessive/alternate eponym spelling where applicable, ICD-10: I21.3, I44.7) is an advanced electrocardiographic (ECG) diagnostic framework designed to identify acute coronary occlusion myocardial infarction (OMI) in patients presenting with left bundle branch block (LBBB) or ventricular paced rhythms1. Traditionally, baseline repolarization abnormalities associated with LBBB—such as discordant ST-segment depression and elevation secondary to abnormal ventricular activation—obscure classic ST-elevation myocardial infarction (STEMI) patterns, historically leading to diagnostic delays and under-treatment. The Smith modification refines the original 1996 Sgarbossa criteria by replacing the rigid, absolute 5-millimeter discordant ST-elevation threshold with a proportional ST-segment to S-wave amplitude ratio (ST/S ratio ≤ -0.25), substantially enhancing diagnostic sensitivity while preserving high specificity for acute epicardial coronary artery occlusion1.

Etiology & Risk Factors

  • Underlying Myocardial Pathology: Acute plaque rupture, fissure, or erosion of an atherosclerotic coronary plaque leading to acute thrombotic occlusion in patients with preexisting conduction system disease1.
  • Cardiovascular Risk Factors: Advanced age, male sex, systemic arterial hypertension, type 2 diabetes mellitus, dyslipidemia, cigarette smoking, chronic kidney disease, and a family history of premature coronary artery disease1.
  • Structural Substrates for LBBB / Paced Rhythm: Hypertensive heart disease, ischemic cardiomyopathy, aortic stenosis, dilated cardiomyopathy, extensive myocardial infarction, prior cardiac surgery, or permanent right ventricular pacing1.

Pathophysiology

The normal electrical activation of the ventricles is fundamentally altered in LBBB and ventricular paced rhythms, resulting in delayed depolarization of the left ventricle and secondary repolarization abnormalities where the ST segment and T wave are directed oppositely to the major QRS deflection (discordance). When an acute transmural myocardial infarction occurs in this setting, the injury current vector points toward the ischemic zone, altering the local repolarization forces. In leads with deep S waves, a large discordant ST-elevation is normally expected; however, excessive ST-elevation relative to the depth of the S wave indicates that true injury current is superimposing upon the baseline discordance. The Smith modification operationalizes this by evaluating the absolute ratio of ST-segment deviation to S-wave depth (ST/S ratio), where a ratio of -0.25 or more negative (i.e., the ST elevation is greater than 25% of the depth of the preceding S wave) accurately detects acute coronary occlusion regardless of absolute millimeter height1.

Smith-modified Sgarbossa criteria — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Coronary plaque rupture or erosion resulting in acute thrombotic occlusion of a coronary artery in a patient with pre-existing LBBB or paced rhythm. 2 Cellular / Pathophysiological Cascade Transmural myocardial ischemia leading to altered repolarization vector that aligns with or exaggerates intrinsic LBBB/paced depolarization abnormalities. 3 Target Organ / Structural Change Left ventricular myocardial injury and necrosis manifesting as abnormal ST-segment shifts on surface electrocardiogram. 4 Hallmark Clinical & Diagnostic Manifestation Electrocardiographic fulfillment of Smith-modified Sgarbossa criteria (concordant ST elevation ≥1 mm or proportional excessive ST discordance with ST/S ratio ≤ -0.25). 5 Complications if Untreated & Therapeutic Target Cardiogenic shock, ventricular arrhythmias, and myocardial rupture; prevented by urgent reperfusion therapy.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Acute retrosternal chest pressure, tightness, or crushing pain often radiating to the left arm, neck, jaw, or epigastrium. Associated autonomic symptoms include diaphoresis, nausea, vomiting, lightheadedness, and acute dyspnoea due to secondary left ventricular dysfunction and elevated filling pressures1.
  • Physical Examination & Named Clinical Signs: Patient appears acutely distressed, anxious, and diaphoretic. Vital signs may reveal tachycardia, hypertension, or conversely hypotension and signs of cardiogenic shock in massive infarctions. Cardiac auscultation may detect a new fourth heart sound (S4 gallop), paradoxical splitting of the second heart sound, or a transient systolic murmur of acute mitral regurgitation resulting from papillary muscle ischemia1.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationUrgent invasive coronary angiography demonstrating acute thrombotic occlusion or critical high-grade stenosis of an epicardial coronary artery (most commonly the left anterior descending artery).
Laboratory PanelSerial high-sensitivity cardiac troponin I or T elevation above the 99th percentile upper reference limit with a dynamic rise and/or fall; complete blood count, lipid panel, comprehensive metabolic panel, and coagulation studies.
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography to evaluate for pulmonary congestion, cardiomegaly, or alternative thoracic pathology (aortic dissection); emergency echocardiography showing new regional wall motion abnormalities or reduced left ventricular ejection fraction.
ECG / Histopathology / Procedural12-lead electrocardiogram demonstrating LBBB or paced rhythm meeting Smith-modified Sgarbossa criteria (concordant ST elevation ≥1 mm, concordant ST depression ≥1 mm in V1–V3, or proportional excessive discordant ST elevation with an ST/S ratio ≤ -0.25).

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Criterion 1: Concordant ST ElevationST-elevation ≥ 1 mm in any lead with a positive QRS complex (concordant with QRS). Highly specific for acute myocardial infarction; score of 5 in original weighting.
Criterion 2: Concordant ST DepressionST-depression ≥ 1 mm in leads V1, V2, or V3 with a negative QRS complex. Indicates posterior or inferolateral injury; score of 3 in original weighting.
Criterion 3: Proportional Excessive Discordance (Smith Modification)ST-elevation with an ST/S ratio ≤ -0.25 (i.e., discordant ST-elevation measuring ≥ 25% of the depth of the preceding S-wave). Replaces the original rigid ≥ 5 mm rule, substantially increasing diagnostic sensitivity.
Clinical Interpretation ThresholdA cumulative score or presence of any single modified criterion indicates ST-elevation myocardial infarction (STEMI) equivalent, mandating immediate activation of primary percutaneous coronary intervention pathways.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Chronic Baseline LBBBStable baseline ECG abnormalities without dynamic serial changes, absence of acute ischemic symptoms, and normal serial cardiac biomarkers.
Left Ventricular Hypertrophy (LVH) with StrainIncreased QRS voltage criteria (Sokolow-Lyon or Cornell) with asymmetric ST-depression and T-wave inversion in lateral leads, lacking acute evolutionary changes or biomarker elevation.
Acute PericarditisWidespread concave upward ST-elevation accompanied by PR segment depression, absence of reciprocal ST depression, and pleuritic chest pain relieved by leaning forward.
Takotsubo CardiomyopathyAcute chest pain and ECG changes mimicking OMI but associated with characteristic apical ballooning on ventriculography/echocardiography and minimal biomarker elevation relative to extensive wall motion abnormalities.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Continuous cardiac telemetry, pulse oximetry, and immediate establishment of intravenous access. Administer supplemental oxygen only if oxygen saturation falls below 90%. Pain relief via intravenous titration of morphine (2–5 mg IV every 5–15 minutes as needed)1.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Dual antiplatelet therapy consisting of a loading dose of aspirin 300 mg PO (chewed) followed by 75–100 mg PO daily, plus either ticagrelor 180 mg PO loading dose (followed by 90 mg BID) or clopidogrel 300–600 mg PO loading dose (followed by 75 mg daily). Procedural anticoagulation with unfractionated heparin administered as an initial IV bolus of 70–100 units/kg (or 50–70 units/kg if glycoprotein IIb/IIIa inhibitor is co-administered) targeting an activated clotting time (ACT) of 250–300 seconds1.
  • Surgical / Interventional Indications: Immediate transfer for primary percutaneous coronary intervention (PPCI) with a target medical contact-to-balloon time of ≤ 90 minutes (or ≤ 120 minutes if interhospital transfer is required). If timely PPCI within 120 minutes is unachievable, administer weight-adjusted fibrinolytic therapy (e.g., tenecteplase IV bolus based on weight) within 30 minutes of arrival, provided no absolute contraindications exist1.

Complications & Prognosis

  • Acute Complications: Mechanical complications including acute papillary muscle rupture with severe mitral regurgitation, ventricular septal rupture, free wall rupture, ventricular arrhythmias (ventricular fibrillation, sustained ventricular tachycardia), acute heart failure, and cardiogenic shock1.
  • Long-Term Prognosis: Heavily dependent on prompt restoration of epicardial coronary flow, baseline left ventricular ejection fraction, extent of myocardial salvage, and timely initiation of secondary prevention guidelines-directed medical therapy (beta-blockers, ACE inhibitors/ARBs, statins)1.